NASDAQ:CDTX
Delisted

Cidara Therapeutics Stock Predictions

etoro logo Buy CDTX
*Your capital is at risk
$221.38
+0 (+0%)
At Close: Apr 07, 2026
Currently predicting for Mon, 8 Jun 2026

CDTX Prediction Chart

CDTX Predictions History

Latest community submissions for CDTX.
Predictor Target Session Target Price Result Direction Accuracy Score
Oct 14, 2025 $113.49 -2.29% $110.64 V 97.42% 1
Oct 14, 2025 $114.49 -1.43% $110.64 V 96.52% 1
Oct 14, 2025 Bullish $110.64 X 0
Oct 13, 2025 $110.43 -2.32% $116.15 X 95.07% 0
Oct 13, 2025 $111.41 -1.45% $116.15 X 95.92% 0
Oct 13, 2025 Bullish $116.15 V 1
Aug 6, 2025 $63.19 +2.31% $61.99 V 98.06% 1
Aug 6, 2025 $62.66 +1.44% $61.99 V 98.92% 2
Aug 6, 2025 Bullish $61.99 X 1
May 7, 2025 $20.25 +2.77% $18.98 X 93.33% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CDTX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT CIDARA THERAPEUTICS
Cidara Therapeutics
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifungals for the treatment and prevention of invasive fungal infections, including candidemia and invasive...
GOLDEN STAR
Ticker Change Signal Date
FISV
0% Nov 30
K
KEEL
0% Nov 30
D
DFTX
0% Nov 30
R
RKLZ
0% Nov 30
R
RKTO
0% Nov 30

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE